Yi Zeng, Ph.D. - Publications

Affiliations: 
2003 University of Arizona, Tucson, AZ 
Area:
Immunology, Oncology

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Ye Z, Zeng Y, Wei S, Wang Y, Lin Z, Lin Z, Chen X, Chen L. [Feasibility of No.8p lymphadenectomy for the patients with advanced gastric cancer]. Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery. 21: 1129-1135. PMID 30370511  0.6
2018 Stokes J, Hoffman EA, Molina MS, Eremija J, Larmonier N, Zeng Y, Katsanis E. Bendamustine with total body irradiation limits murine graft-versus-host disease in part through effects on myeloid-derived suppressor cells. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30326280 DOI: 10.1016/j.bbmt.2018.10.009  1
2018 Wang M, Wang W, Leow WR, Wan C, Chen G, Zeng Y, Yu J, Liu Y, Cai P, Wang H, Ielmini D, Chen X. Enhancing the Matrix Addressing of Flexible Sensory Arrays by a Highly Nonlinear Threshold Switch. Advanced Materials (Deerfield Beach, Fla.). e1802516. PMID 29971867 DOI: 10.1002/adma.201802516  0.6
2018 Katsanis E, Sapp LN, Varner N, Koza S, Stea B, Zeng Y. Haploidentical bone marrow transplantation with post-transplant cyclophosphamide/bendamustine in pediatric and young adult patients with hematologic malignancies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29908231 DOI: 10.1016/j.bbmt.2018.06.007  1
2018 Tang K, Wang F, Zeng Y, Chen X, Xu X. Salusin-α attenuates hepatic steatosis and atherosclerosis in high fat diet-fed low density lipoprotein receptor deficient mice. European Journal of Pharmacology. PMID 29704496 DOI: 10.1016/j.ejphar.2018.04.026  0.6
2018 Li B, Liu Y, Wan C, Liu Z, Wang M, Qi D, Yu J, Cai P, Xiao M, Zeng Y, Chen X. Mediating Short-Term Plasticity in an Artificial Memristive Synapse by the Orientation of Silica Mesopores. Advanced Materials (Deerfield Beach, Fla.). e1706395. PMID 29544021 DOI: 10.1002/adma.201706395  0.6
2018 Chen L, Wei S, Ye Z, Xiao J, Zeng Y, Wang Y, Lin Z, Lin Z, Chen X. [D2 radical resection of omental bursa and No.12p and No.8p for gastric carcinoma: a retrospectively analysis from a single center in China]. Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery. 21: 196-200. PMID 29492920  0.6
2017 Zeng Y, Hahn S, Stokes J, Hoffman EA, Schmelz M, Proytcheva M, Chernoff J, Katsanis E. Pak2 regulates myeloid-derived suppressor cell development in mice. Blood Advances. 1: 1923-1933. PMID 29296839 DOI: 10.1182/bloodadvances.2017007435  1
2017 Lv Z, Luo Y, Tang Y, Wei J, Zhu Z, Zhou X, Li W, Zeng Y, Zhang W, Zhang Y, Qi D, Pan S, Loh XJ, Chen X. Editable Supercapacitors with Customizable Stretchability Based on Mechanically Strengthened Ultralong MnO2 Nanowire Composite. Advanced Materials (Deerfield Beach, Fla.). PMID 29134702 DOI: 10.1002/adma.201704531  0.6
2017 Zeng Y, Katsanis E. Potential niche indications for blinatumomab as a bridge to hematopoietic cell transplantation. Bone Marrow Transplantation. PMID 28920946 DOI: 10.1038/bmt.2017.186  1
2017 Liu TT, Zeng Y, Tang K, Chen X, Zhang W, Xu XL. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice. Atherosclerosis. 262: 39-50. PMID 28500865 DOI: 10.1016/j.atherosclerosis.2017.05.003  0.6
2016 Katsanis E, Sapp LN, Pelayo-Katsanis L, Whitney K, Zeng Y, Kopp LM. Alternative Donor Hematopoietic Cell Transplantation Conditioned With Myeloablative Busulfan, Fludarabine, and Melphalan is Well Tolerated and Effective Against High-risk Myeloid Malignancies. Journal of Pediatric Hematology/Oncology. PMID 27467368 DOI: 10.1097/MPH.0000000000000621  1
2016 Stokes J, Hoffman EA, Zeng Y, Larmonier N, Katsanis E. Post-transplant bendamustine reduces GvHD while preserving GvL in experimental haploidentical bone marrow transplantation. British Journal of Haematology. PMID 27030315 DOI: 10.1111/bjh.14034  0.44
2015 Wu X, Lin Q, Chen G, Lu J, Zeng Y, Chen X, Yan J. Sentinel Lymph Node Detection Using Carbon Nanoparticles in Patients with Early Breast Cancer. Plos One. 10: e0135714. PMID 26296136 DOI: 10.1371/journal.pone.0135714  0.6
2015 Zhao Y, Guo Y, Wang Z, Xiao Z, Li R, Luo A, Wu C, Jing Z, Sun N, Chen X, Du H, Zeng Y. GALC gene is downregulated by promoter hypermethylation in Epstein-Barr virus-associated nasopharyngeal carcinoma. Oncology Reports. PMID 26178533 DOI: 10.3892/or.2015.4134  0.6
2015 Zeng Y, Yu Y, Feng H, King RB, Schaefer HF. Nickelacyclopentadienylchromium tricarbonyl unit as a bulky pseudohalogen in cyclopentadienylchromium complexes leading to low-energy high-spin structures. Inorganic Chemistry. 54: 5309-15. PMID 25978069 DOI: 10.1021/acs.inorgchem.5b00362  0.36
2015 Li H, Tang J, Chen L, Liao Y, Zhou B, He Y, Li Z, Lv L, Zeng Y, Chen X. Reduced middle cingulate gyrus volume in late-onset schizophrenia in a Chinese Han population: a voxel-based structural MRI study. Neuroscience Bulletin. PMID 25956581 DOI: 10.1007/s12264-015-1525-1  0.6
2015 Zeng Y, Katsanis E. The complex pathophysiology of acquired aplastic anaemia. Clinical and Experimental Immunology. 180: 361-70. PMID 25683099 DOI: 10.1111/cei.12605  1
2015 Zeng Y, Broxmeyer HE, Staser K, Chitteti BR, Park SJ, Hahn S, Cooper S, Sun Z, Jiang L, Yang X, Yuan J, Kosoff R, Sandusky G, Srour EF, Chernoff J, et al. Pak2 regulates hematopoietic progenitor cell proliferation, survival, and differentiation. Stem Cells (Dayton, Ohio). 33: 1630-41. PMID 25586960 DOI: 10.1002/stem.1951  1
2014 Zeng Y, Stokes J, Hahn S, Hoffman E, Katsanis E. Activated MHC-mismatched T helper-1 lymphocyte infusion enhances GvL with limited GvHD. Bone Marrow Transplantation. 49: 1076-83. PMID 24777185 DOI: 10.1038/bmt.2014.91  1
2007 Li G, Zeng Y, Chen X, Larmonier N, Sepassi M, Graner MW, Andreansky S, Brewer MA, Katsanis E. Human ovarian tumour-derived chaperone-rich cell lysate (CRCL) elicits T cell responses in vitro. Clinical and Experimental Immunology. 148: 136-45. PMID 17349014 DOI: 10.1111/j.1365-2249.2007.03323.x  1
2007 Larmonier N, Marron M, Zeng Y, Cantrell J, Romanoski A, Sepassi M, Thompson S, Chen X, Andreansky S, Katsanis E. Tumor-derived CD4(+)CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10. Cancer Immunology, Immunotherapy : Cii. 56: 48-59. PMID 16612596 DOI: 10.1007/s00262-006-0160-8  1
2006 Zeng Y, Chen X, Larmonier N, Larmonier C, Li G, Sepassi M, Marron M, Andreansky S, Katsanis E. Natural killer cells play a key role in the antitumor immunity generated by chaperone-rich cell lysate vaccination. International Journal of Cancer. Journal International Du Cancer. 119: 2624-31. PMID 16989012 DOI: 10.1002/ijc.22150  1
2006 Chen X, Zeng Y, Li G, Larmonier N, Graner MW, Katsanis E. Peritransplantation vaccination with chaperone-rich cell lysate induces antileukemia immunity. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 12: 275-83. PMID 16503496 DOI: 10.1016/j.bbmt.2006.01.001  1
2006 Zeng Y, Graner MW, Katsanis E. Chaperone-rich cell lysates, immune activation and tumor vaccination. Cancer Immunology, Immunotherapy : Cii. 55: 329-38. PMID 15887013 DOI: 10.1007/s00262-005-0694-1  1
2005 Zeng Y, Graner MW, Thompson S, Marron M, Katsanis E. Induction of BCR-ABL-specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cells. Blood. 105: 2016-22. PMID 15374884 DOI: 10.1182/blood-2004-05-1915  1
2004 Feng H, Zeng Y, Graner MW, Whitesell L, Katsanis E. Evidence for a Novel, Caspase-8-Independent, Fas Death Domain-Mediated Apoptotic Pathway. Journal of Biomedicine & Biotechnology. 2004: 41-51. PMID 15123887 DOI: 10.1155/S1110724304308041  1
2004 Zeng Y, Graner MW, Feng H, Li G, Katsanis E. Imatinib mesylate effectively combines with chaperone-rich cell lysate-loaded dendritic cells to treat bcr-abl+ murine leukemia. International Journal of Cancer. Journal International Du Cancer. 110: 251-9. PMID 15069690 DOI: 10.1002/ijc.20115  1
2003 Graner MW, Zeng Y, Feng H, Katsanis E. Tumor-derived chaperone-rich cell lysates are effective therapeutic vaccines against a variety of cancers. Cancer Immunology, Immunotherapy : Cii. 52: 226-34. PMID 12669247 DOI: 10.1007/s00262-002-0359-2  1
2003 Zeng Y, Feng H, Graner MW, Katsanis E. Tumor-derived, chaperone-rich cell lysate activates dendritic cells and elicits potent antitumor immunity. Blood. 101: 4485-91. PMID 12576309 DOI: 10.1182/blood-2002-10-3108  1
2003 Feng H, Zeng Y, Graner MW, Likhacheva A, Katsanis E. Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunity. Blood. 101: 245-52. PMID 12393411 DOI: 10.1182/blood-2002-05-1580  1
2002 Feng H, Zeng Y, Graner MW, Katsanis E. Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells. Blood. 100: 4108-15. PMID 12393401 DOI: 10.1182/blood-2002-05-1389  1
2001 Feng H, Zeng Y, Whitesell L, Katsanis E. Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunity. Blood. 97: 3505-12. PMID 11369644 DOI: 10.1182/blood.V97.11.3505  1
2001 He L, Feng H, Raymond A, Kreeger M, Zeng Y, Graner M, Whitesell L, Katsanis E. Dendritic-cell-peptide immunization provides immunoprotection against bcr-abl-positive leukemia in mice. Cancer Immunology, Immunotherapy : Cii. 50: 31-40. PMID 11315508  1
Show low-probability matches.